Yan Shen1, Li Wen2,3, Rui Zhang1, Zeliang Wei1, Na Shi2, Qiuyang Xiong1, Qing Xia2, Zhihua Xing1, Zhi Zeng1, Hai Niu1,4, Wen Huang1. 1. Laboratory of Ethnopharmacology/Regenerative Medicine Research Center, West China Hospital/West China Medical School, Sichuan University, Chengdu, Sichuan, China. 2. Department of Integrated Traditional Chinese and Western Medicine, West China Hospital/West China Medical School, Sichuan University, Chengdu, Sichuan, China. 3. Department of Pediatric Gastroenterology, Children's Hospital of Pittsburgh of UPMC and School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. 4. College of Mathematics, Sichuan University, Chengdu, Sichuan, China.
Abstract
BACKGROUND AND PURPOSE: Acute pancreatitis (AP) is a painful and distressing disorder of the exocrine pancreas with no specific treatment. Diosgenyl saponins extracted from from Dioscorea zingiberensis C. H. Wright have been reported to protect against experimental models of AP. Diosgenin, or its derivatives are anti-inflammatory in various conditions. However, the effects of diosgenin and its spiroacetal ring opened analogue, dihydrodiosgenin (Dydio), on AP have not been determined. EXPERIMENTAL APPROACH: Effects of diosgenin and Dydio on sodium taurocholate hydrate (Tauro)-induced necrosis were tested, using freshly isolated murine pancreatic acinar cells. Effects of Dydio on mitochondrial dysfunction in response to Tauro, cholecystokinin-8 and palmitoleic acid ethyl ester were also assessed. Dydio (5 or 10 mg·kg-1 ) was administered after the induction in vivo of Tauro-induced AP (Wistar rats), caerulein-induced AP and palmitoleic acid plus ethanol-induced AP (Balb/c mice). Pancreatitis was assessed biochemically and histologically. Activation of pancreatic PI3Kγ/Akt was measured by immunoblotting. KEY RESULTS: Dydio inhibited Tauro-induced activation of the necrotic cell death pathway and prevented pancreatitis stimuli-induced mitochondrial dysfunction. Therapeutic administration of Dydio ameliorated biochemical and histopathological responses in all three models of AP through pancreatic mitochondrial protection and PI3Kγ/Akt inactivation. Moreover, Dydio improved pancreatitis-associated acute lung injury through preventing excessive inflammatory responses. CONCLUSION AND IMPLICATIONS: These data provide in vitro and in vivo mechanistic evidence that the diosgenin analogue, Dydio could be potential treatment for AP. Further medicinal optimization of diosgenin and its analogue might be a useful strategy for identifying lead candidates for inflammatory diseases.
BACKGROUND AND PURPOSE: Acute pancreatitis (AP) is a painful and distressing disorder of the exocrine pancreas with no specific treatment. Diosgenyl saponins extracted from from Dioscorea zingiberensis C. H. Wright have been reported to protect against experimental models of AP. Diosgenin, or its derivatives are anti-inflammatory in various conditions. However, the effects of diosgenin and its spiroacetal ring opened analogue, dihydrodiosgenin (Dydio), on AP have not been determined. EXPERIMENTAL APPROACH: Effects of diosgenin and Dydio on sodium taurocholate hydrate (Tauro)-induced necrosis were tested, using freshly isolated murine pancreatic acinar cells. Effects of Dydio on mitochondrial dysfunction in response to Tauro, cholecystokinin-8 and palmitoleic acid ethyl ester were also assessed. Dydio (5 or 10 mg·kg-1 ) was administered after the induction in vivo of Tauro-induced AP (Wistar rats), caerulein-induced AP and palmitoleic acid plus ethanol-induced AP (Balb/c mice). Pancreatitis was assessed biochemically and histologically. Activation of pancreatic PI3Kγ/Akt was measured by immunoblotting. KEY RESULTS:Dydio inhibited Tauro-induced activation of the necrotic cell death pathway and prevented pancreatitis stimuli-induced mitochondrial dysfunction. Therapeutic administration of Dydio ameliorated biochemical and histopathological responses in all three models of AP through pancreatic mitochondrial protection and PI3Kγ/Akt inactivation. Moreover, Dydio improved pancreatitis-associated acute lung injury through preventing excessive inflammatory responses. CONCLUSION AND IMPLICATIONS: These data provide in vitro and in vivo mechanistic evidence that the diosgenin analogue, Dydio could be potential treatment for AP. Further medicinal optimization of diosgenin and its analogue might be a useful strategy for identifying lead candidates for inflammatory diseases.
Authors: M Celeste Del Fueyo; M Virginia Dansey; Luciano S Paolo; Adalí Pecci; Adriana S Veleiro; Gerardo Burton Journal: Steroids Date: 2016-05-26 Impact factor: 2.668
Authors: Gyorgy Biczo; Eszter T Vegh; Natalia Shalbueva; Olga A Mareninova; Jason Elperin; Ethan Lotshaw; Sophie Gretler; Aurelia Lugea; Sudarshan R Malla; David Dawson; Piotr Ruchala; Julian Whitelegge; Samuel W French; Li Wen; Sohail Z Husain; Fred S Gorelick; Peter Hegyi; Zoltan Rakonczay; Ilya Gukovsky; Anna S Gukovskaya Journal: Gastroenterology Date: 2017-10-23 Impact factor: 22.682
Authors: Rajarshi Mukherjee; Olga A Mareninova; Irina V Odinokova; Wei Huang; John Murphy; Michael Chvanov; Muhammad A Javed; Li Wen; David M Booth; Matthew C Cane; Muhammad Awais; Bruno Gavillet; Rebecca M Pruss; Sophie Schaller; Jeffery D Molkentin; Alexei V Tepikin; Ole H Petersen; Stephen J Pandol; Ilya Gukovsky; David N Criddle; Anna S Gukovskaya; Robert Sutton Journal: Gut Date: 2015-06-12 Impact factor: 23.059
Authors: Wei Huang; David M Booth; Matthew C Cane; Michael Chvanov; Muhammad A Javed; Victoria L Elliott; Jane A Armstrong; Hayley Dingsdale; Nicole Cash; Yan Li; William Greenhalf; Rajarshi Mukherjee; Bhupendra S Kaphalia; Mohammed Jaffar; Ole H Petersen; Alexei V Tepikin; Robert Sutton; David N Criddle Journal: Gut Date: 2013-10-25 Impact factor: 23.059
Authors: Angelo A Izzo; Mauro Teixeira; Steve P H Alexander; Giuseppe Cirino; James R Docherty; Christopher H George; Paul A Insel; Yong Ji; David A Kendall; Reynold A Panattieri; Christopher G Sobey; S Clare Stanford; Barbara Stefanska; Gary Stephens; Amrita Ahluwalia Journal: Br J Pharmacol Date: 2020-04-16 Impact factor: 8.739